Beyond their established role in T2D, GLP-1RAs are under investigation for potential therapeutic applications in additional clinical domains: non-alcoholic fatty liver disease (NAFLD) [22], neurodegenerative conditions [23], and addiction reduction(including smoking, alcohol use disorder, and cocaine use disorder, putatively via mechanisms analogous to those underlying appetite suppression) [23]
Selected entries are chosen based on the type of product and the potential safety impact of the recall or warning
Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019
I think theres going to be a lot of development around whats the right delivery form. As foods and drugs are regulated differently, we wont see GLP-1 mimics like semaglutide incorporated into foods any time soon, he clarified, But I think solutions should be holistic
Let's take a closer look at what GLP-1 is and how it can help you in your pursuit of a better metabolism